A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.
With a two-year option license agreement from Case Western Reserve University’s Technology Transfer Office (TTO), Apollo Medical Devices LLC (Apollo) plans to further advance toward commercialization a point-of-care blood tester to fill that need.
An option agreement allows time for a company to demonstrate it can make a technology commercially viable by proof of concept and attracting investment.
For nearly half a century, scientists have been trying to replace precious metal catalysts in fuel cells. Now, for the first time, researchers at Case Western Reserve University have shown that an inexpensive metal-free catalyst performs as well as costly metal catalysts at speeding the oxygen reduction reaction in an acidic fuel cell.
The carbon-based catalyst also corrodes less than metal-based materials and has proved more durable.
Matthew Willard, associate professor of materials science and engineering, was selected as one of four 2015 Brimacombe Medalists for his achievements in materials science and engineering by the Minerals, Metals and Materials Society (TMS). He was selected for this honor from the nearly 10,000 professional and student members consisting of metallurgical and materials engineers, scientists, researchers, educators and administrators from more than 70 countries on six continents.
A new partnership between Nottingham Spirk, a global product design and business innovation firm known for creating some of the world’s most popular consumer items, and Case Western Reserve University will engage and inspire the next generation of inventors in new ways.
Nottingham Spirk will create an environment of partnership and innovation on the first level of Case Western Reserve’s seven-story think[box] innovation center. The company is also partnering with faculty members to develop high-quality concepts into marketable products faster and to protect those innovations with additional intellectual property.
Anant Madabhushi, professor of biomedical engineering and director of the Center for Computational Imaging and Personalized Diagnostics, has been elected unanimously to the National Cancer Institute's Quantitative Imaging Network (QIN).
The network is designed to promote research and development of quantitative imaging methods for the measurement of tumor response to therapies in clinical trial settings, with the overall goal of facilitating clinical decision-making.